Literature DB >> 24719338

Coronary microvascular dysfunction assessed by intracoronary acetylcholine provocation testing is a frequent cause of ischemia and angina in patients with exercise-induced electrocardiographic changes and unobstructed coronary arteries.

Peter Ong1, Anastasios Athanasiadis, Stephan Hill, Tim Schäufele, Heiko Mahrholdt, Udo Sechtem.   

Abstract

BACKGROUND: The exercise electrocardiogram (ECG) is a standard examination in patients with suspected coronary artery disease. However, despite a pathologic result, many patients undergoing diagnostic coronary angiography do not have any significant epicardial stenosis. In this study, we assessed the relation between a pathologic exercise ECG and coronary microvascular dysfunction in response to intracoronary acetylcholine (ACh) provocation in patients without any relevant epicardial stenosis. HYPOTHESIS: Coronary microvascular dysfunction is significantly more often in patients with angina, unobstructed coronary arteries and a pathologic exercise stress test compared to those without pathologic stress test.
METHODS: This study recruited 137 consecutive patients with exertional angina pectoris who underwent diagnostic coronary angiography between September 2008 and April 2011 (68% women; mean age, 63 ± 10 years). In none of the patients was there a stenosis of >50%. All patients underwent an exercise ECG before angiography and intracoronary ACh provocation testing for assessment of coronary vasomotor responses directly after angiography.
RESULTS: The exercise ECG showed an abnormal result in 69 patients (50%; ST-segment depression ≥0.1 mV and/or reproduction of the patient's usual symptoms). The ACh test revealed a coronary vasomotor abnormality (reproduction of the patient's symptoms, ischemic ECG shifts ± diffuse distal vasoconstriction) in 87 patients (64%). Such a result was significantly more often found in patients with a pathologic exercise ECG (50/69 [72%] vs 19/69 [28%], P = 0.034). There were no other statistically significant differences between patients with and those without pathologic exercise ECG.
CONCLUSIONS: Coronary microvascular dysfunction is frequently found in patients with exertional angina pectoris and unobstructed coronary arteries. Such a finding is found significantly more often in presence of a pathologic exercise ECG.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24719338      PMCID: PMC6649571          DOI: 10.1002/clc.22282

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  11 in total

1.  Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry.

Authors:  Mauro Gitto; Francesco Gentile; Alexandra N Nowbar; Alaide Chieffo; Rasha Al-Lamee
Journal:  Int J Angiol       Date:  2020-05-14

Review 2.  Overview of the Acetylcholine Spasm Provocation Test.

Authors:  Shozo Sueda; Hiroaki Kohno; Takaaki Ochi; Tadao Uraoka
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

3.  Current Diagnostic and Therapeutic Strategies in Microvascular Angina.

Authors:  Bryn Mumma; Nathalie Flacke
Journal:  Curr Emerg Hosp Med Rep       Date:  2015-03

4.  Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease.

Authors:  Diana M Lopez; Sanjay Divakaran; Ankur Gupta; Navkaranbir S Bajaj; Michael T Osborne; Wunan Zhou; Jon Hainer; Courtney F Bibbo; Hicham Skali; Sharmila Dorbala; Viviany R Taqueti; Ron Blankstein; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2021-08-18

5.  Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.

Authors:  Harmony R Reynolds; Michael H Picard; John A Spertus; Jesus Peteiro; Jose Luis Lopez Sendon; Roxy Senior; Mohammad C El-Hajjar; Jelena Celutkiene; Michael D Shapiro; Patricia A Pellikka; Dennis F Kunichoff; Rebecca Anthopolos; Khaled Alfakih; Khaled Abdul-Nour; Michel Khouri; Leonid Bershtein; Mark De Belder; Kian Keong Poh; John F Beltrame; James K Min; Jerome L Fleg; Yi Li; David J Maron; Judith S Hochman
Journal:  Circulation       Date:  2021-06-01       Impact factor: 39.918

6.  Treatment of Stable Angina Pectoris With Ivabradine in Everyday Practice: A Pan-Hellenic, Prospective, Noninterventional Study.

Authors:  John Zarifis; Violetta Grammatikou; Manolis Kallistratos; Apostolos Katsivas
Journal:  Clin Cardiol       Date:  2015-11-19       Impact factor: 2.882

Review 7.  Women and Chest Pain: Recognizing the Different Faces of Angina in the Emergency Department.

Authors:  Basmah Safdar; Gail D'Onofrio
Journal:  Yale J Biol Med       Date:  2016-06-27

8.  Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.

Authors:  J Zarifis; V Grammatikou; M Kallistratos; A Katsivas
Journal:  Angiology       Date:  2016-03-08       Impact factor: 3.619

9.  Characterization of the Human Coronary Microvascular Response to Multiple Hyperaemic Agents.

Authors:  Massimo Nardone; Mary McCarthy; Chris I Ardern; Heather Edgell; Olga Toleva; Lynne E Nield; Steven E S Miner
Journal:  CJC Open       Date:  2020-09-25

10.  Pharmacological and simulated exercise cardiac stress tests produce different ischemic signatures in high-resolution experimental mapping studies.

Authors:  Brian Zenger; Wilson W Good; Jake A Bergquist; Lindsay C Rupp; Maura Perez; Gregory J Stoddard; Vikas Sharma; Rob S MacLeod
Journal:  J Electrocardiol       Date:  2021-07-24       Impact factor: 1.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.